An AI model demonstrated efficacy at identifying moderate to severe depression through speech patterns, according to a ...

Emil Kakkis; President, Chief Executive Officer, Director; Ultragenyx Pharmaceutical Inc Erik Harris; Executive Vice President, Chief Commercial Officer; Ultragenyx Pharmaceutical Inc Howard Horn; ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Blood tests and the adoption of AI in cognitive decline screenings have opened the door to new avenues for testing cognitive ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

As President Donald Trump tries to reduce overhead costs in federal grants, research institutions are trying to explain it's ...

A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...

The study underscores the transformative potential of AI in Alzheimer’s diagnostics. ChatGPT’s ability to analyze EHRs, MRI scans, and cognitive assessments could aid early detection, allowing for ...

The Colonia Safe Water Project is a collaboration between Texas A&M University School of Public Health and Methodist ...

Explore how a holistic, trauma-informed approach to treatment can revolutionize mental health care, moving beyond traditional diagnostic labels to truly heal patients.